Patients being treated with dupilumab for atopic dermatitis may experience less severe Covid-19 symptoms, according to a new study.

Research has suggested that intrauterine mechanisms of overweight women in pre-pregnancy may have increased risks of their infant having AD.

A new study suggests that the use of biologics in patients with inflammatory skin diseases is safe during the Covid-19 pandemic.

Interleukins 4 and 13 appear to drive lipid abnormalities in skin cells through regulation of sex steroid hormone synthesis, according to...

A longitudinal cohort study has found that severe atopic dermatitis (AD) was associated with symptoms of depression and internalizing...

Researchers have identified a subtype of atopic dermatitis that is more likely to worsen into midlife and may be linked to poorer health.

A neonatal dose of the Bacille Calmette-Guérin (BCG) tuberculosis vaccine could reduce the risk of atopic disease in infants with two...

New research has linked dupilumab treatment in atopic dermatitis (AD) patients with an increased prevalence of ocular disease.